Life Sciences

Journal ad for Bystolic misleading

Pharma Compliance Alert, September 10, 2008

Forest Laboratories’ eight-page journal ad for Bystolic claims the drug is safer and more effective than has been demonstrated, according to an FDA warning letter.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   

Most Popular